TEXAS HEART INSTITUTE Patent applications |
Patent application number | Title | Published |
20150148410 | IDENTIFICATION OF SPECIFIC APOLIPOPROTEIN EPITOPES ON CIRCULATING ATHEROGENIC LOW-DENSITY LIPOPROTEIN - An isolated peptidic fragment of apolipoprotein E comprises at least 3 contiguous amino acids, Including glycosylated threonine 194, threonine 289, serine 94, or serine 76 of SEQ ID NO.: 1, or any combination of those. An antibody capable of binding to the isolated peptidic fragment. A method of detecting a naturally-occurring circulating atherogenic low-density lipoprotein in a plasma sample from an individual, comprising qualitatively and/or quantitatively detecting in a low-density lipoprotein that binds to the antibody. A method of assessing an individual's risk of ischemic heart disease and/or atherosclerosis comprises quantifying in a plasma sample from the individual an amount of apolipoprotein E comprising glycosylated threonine 194, threonine 289, serine 94 or serine 76 of SEQ ID NO.: 1, or any combination of those. | 05-28-2015 |
20140065112 | COMPOSITIONS AND METHODS FOR MESENCHYMAL/STROMAL STEM CELL REJUVENATION AND TISSUE REPAIR BY ENHANCED CO-EXPRESSION OF TELOMERASE AND MYOCARDIN - A major risk factor for ischemic heart disease is advanced age. In adult bone marrow and other tissues, the number and function of stem cells decline with aging. Telomerase reverse transcriptase (TERT) is a nuclear protein that decreases senescence. Myocardin (MYOCD) is a transcription factor for myogenesis. Thus a method is provided for the simultaneous delivery of the telomerase reverse transcriptase (TERT) and myocardin MYOCD genes that resuscitates mesenchymal stromal cells (MSCs) from aged adipose and bone marrow tissues by increasing their capacity for survival, proliferation, and differentiation. TERT | 03-06-2014 |
20130236434 | AGONISTS THAT ENHANCE BINDING OF INTEGRIN-EXPRESSING CELLS TO INTEGRIN RECEPTORS - A method of enhancing binding of cells to an integrin-binding ligand comprises treating integrin-expressing cells in vitro with an agonist of integrin, wherein the integrin is selected from the group consisting of α4β1, α5β1, α4β7, αvβ3 and αLβ2, and contacting the treated cells with an integrin-binding ligand; integrin agonist compounds having the general formula I; methods of treating integrin-expressing cells with such agonists to enhance binding; and therapeutic methods comprising administering agonist-treated cells or agonist compounds to a mammal. | 09-12-2013 |
20120220848 | INTRODUCER SHEATH WITH ELECTRODES - An introducer comprise a sheath for introducing a catheter into a blood vessel, a plurality of electrodes on the sheath, and an impedance assessment unit provided on the sheath and connected to the electrodes. The impedance assessment unit fixes one of a current or voltage across a first pair of the electrodes and measures the other of the current or voltage across a second pair of electrodes. | 08-30-2012 |
20110223670 | ETS2 AND MESP1 GENERATE CARDIAC PROGENITORS FROM FIBROBLASTS - A method for modulating cell differentiation capabilities using heterologous gene expression. Some embodiments of the invention relate to a method for inducing a cardiac progenitor cell by delivering a reprogramming factor to the cell, wherein the reprogramming factor comprises ETS2 or a combination of ETS2 and Mesp1. | 09-15-2011 |
20100174170 | INTRODUCER SHEATH WITH ELECTRODES - An apparatus comprises a sheath for introducing a catheter into a blood vessel, at least one electrode provided on the sheath, at least one other electrode; and a measuring device to which at least one pair of electrodes are coupled. The measuring device measures the impedance or conduction velocity between the first electrode on the sheath and the second electrode. | 07-08-2010 |
20100010552 | METHOD AND SYSTEM FOR TEMPERATURE ANALYSIS TO PROVIDE AN EARLY MARKER OF CONGESTIVE HEART FAILURE PROGRESS THAT PRECEDES A PATIENT'S SYMPTOMS - The temperature of a patient is a significant predictor of death in heart failure patients. Temperature provides a window into the physiology of the patient's underlying condition and may be used as an early marker for CHF exacerbations. The patient's temperature is taken to form a time series of temperature values. In accordance with some embodiments, the time series of temperature values is converted to the frequency domain by, for example, a discrete Fourier Transform. The frequency domain representation then is analyzed for a marker indicative of the worsening condition of the patient. In accordance with other embodiments, the patient's time series of temperature values is analyzed for a marker using, for example, Cosinor analysis. In yet other embodiments, both the time and frequency domain temperature data is analyzed for markers of the patient's worsening medical condition. | 01-14-2010 |
20090112182 | METHOD AND APPARATUS FOR VASCULAR ACCESS - A vascular access device comprises a bridge having first and second bores therethrough, a dilator in the first bore, and a needle guide in the second bore. The second bore is at an angle with respect to the first bore such that the needle guide is at the angle with respect to the dilator. The device is useful, for example to achieve dual site entrance to a blood vessel. | 04-30-2009 |
20080200978 | Surgical System and Method For Attaching a Prosthetic Vessel to a Hollow Structure - A system and method for joining an end of a tubular prosthesis to the wall of a vessel wherein an anvil is inserted into the vessel through an opening in the vessel wall produced by a cutting surface on the anvil. The anvil is operated via an anvil handle which may extend through the tubular prosthesis. The tubular prosthesis is guided to the opening in the vessel wall whereupon jaws clamp the prosthesis around the anvil. Staples mounted on the jaws engage the anvil and are bent to thereby staple the end of the tubular prosthesis to the vessel wall. A cutting edge may be mounted to the anvil and utilized to create an enlarged hole to permit blood flow into the tubular prosthesis and to permit removal of the anvil from the vessel. | 08-21-2008 |